Treatment |
Blood Glucose, mM |
Onset of Experiment |
End of Experiment |
Group I
(untreated control) |
5,7 ± 0.31 |
5.9 ± 0.42 |
Group II
(STZ) |
5.8 ± 0.32 |
14.6 ± 2.40* |
Group III
(C60HyFn control) |
5.6 ± 0.30 |
5.5 ± 0.19 |
Group IV
(C60HyFn prophylactic regime + STZ) |
5.3 ± 0.42 |
13.8 ± 1.70* |
Group V
(STZ + C60HyFn therapeutic regime) |
6.1 ± 0.53 |
15.1 ± 2.21* |
*P<0.05 vs. intact control (Group I) |